Harnessing Extracellular Vesicles for Targeted Drug Delivery in Ovarian Cancer
Ovarian cancer remains one Flags of the most lethal gynecologic malignancies, primarily due to late-stage diagnosis, high recurrence rates, and the development of chemoresistance.Although targeted therapies have improved patient outcomes, their efficacy is often limited by off-target toxicity and acquired drug resistance.Extracellular vesicles (EVs